EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of NEUROG1 methylation status in stool specimens in the advanced adenomas and colorectal cancer

Lijin Zhang, Aiping Lin, Jie Lin, Juan Chen, Mengshi Chen, Xunbin Yu, Yijuan Wu, Tao Wang, Yan Lu, Zhaofen Ba, Xiaowei Cheng, Tiantian Zhang und 1 weitere

PeerJ · 2025

DOI: 10.7717/peerj.19968 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Lijin Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, the Shengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenoma, DNA Methylation, Feces. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To assess the status of NEUROG1 methylation in the advanced adenoma and colorectal cancer.

Methods

The NEUROG1 methylation in tissue and stool samples from patients with colorectal cancer (CRC), advanced adenoma (AA), and non-advanced adenoma (NAA) were evaluated using methylation-specific quantitative polymerase chain reaction (PCR).

Results

In tissue samples, the NEUROG1 methylation detection rates were 36% for CRC, 24% for NAA, and 88% for AA. In stool samples, the NEUROG1 methylation detection had a sensitivity of 63.46% for CRC with a positive predictive value (PPV) of 85.94%. The overall diagnostic specificity of the test for the NAA and the healthy control was 76.32%, with a negative predictive value (NPV) of 40.28%.

Conclusion

NEUROG1 methylation detection can potentially be used in the CRC and AA screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAdenomaDNA MethylationFecesBasic Helix-Loop-Helix ProteinsNerve Tissue ProteinsHumansMaleFemaleMiddle AgedAgedSensitivity and SpecificityBiomarkers, TumorAdult

Stichwörter der Autor:innen

Colorectal cancerDNA methylationDiagnosisNEUROG1Stool

Substanzen

Basic Helix-Loop-Helix ProteinsNerve Tissue ProteinsBiomarkers, TumorNEUROG1 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology, the Shengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
  • Department of Gastroenterology, Fujian Provincial Hospital, Fuzhou, Fujian, China.
  • Department of Gastroenterology, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, China.
  • Department of Pathology, Fujian Provincial Hospital, Fuzhou, Fujian, China.
  • Jiangsu Microdiag Biomedical Technology Co., LTD, Suzhou, Jiangsu, China.

Förderung

  • Natural Science Foundation of Fujian Province, China

Zitieren

APA

Zhang, L., Lin, A., Lin, J., Chen, J., Chen, M., Yu, X., Wu, Y., Wang, T., Lu, Y., Ba, Z., Cheng, X., Zhang, T., & Chen, M. (2025). Evaluation of NEUROG1 methylation status in stool specimens in the advanced adenomas and colorectal cancer. PeerJ. https://doi.org/10.7717/peerj.19968

Vancouver

Zhang L, Lin A, Lin J, Chen J, Chen M, Yu X, et al. Evaluation of NEUROG1 methylation status in stool specimens in the advanced adenomas and colorectal cancer. PeerJ. 2025. doi:10.7717/peerj.19968

BibTeX
@article{Zhang2025,
  author = {Zhang, Lijin and Lin, Aiping and Lin, Jie and Chen, Juan and Chen, Mengshi and Yu, Xunbin and Wu, Yijuan and Wang, Tao and Lu, Yan and Ba, Zhaofen and Cheng, Xiaowei and Zhang, Tiantian and Chen, Minghong},
  title = {Evaluation of NEUROG1 methylation status in stool specimens in the advanced adenomas and colorectal cancer},
  journal = {PeerJ},
  year = {2025},
  doi = {10.7717/peerj.19968}
}
Kostenlos starten →